BIOTALYS NV (BTLS.BR) Stock Income Statement
EBR:BTLS - Euronext Brussels - BE0974386188 - Common Stock - Currency: EUR
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 13.49M | 20.89M | 22.53M | 18.08M | 13.28M | |||
| Research and Development | 10.96M | 16.61M | 18.81M | 13.88M | 11.49M | |||
| Selling, General, and Administrative Expenses | 5.72M | 6.89M | 6.67M | 6.19M | 3.18M | |||
| Operating Income | -13.49M | -20.89M | -22.53M | -18.08M | -13.28M | |||
| Interest Income/Expense | -168.00K | -189.00K | -243.00K | 1.20M | 2.56M | |||
| Other Income/Expense | 512.00K | 626.00K | 5.00K | -30.00K | -20.00K | |||
| Income Before Taxes | -13.15M | -20.45M | -22.77M | -16.91M | -10.74M | |||
| Income Tax | 40.00K | 56.00K | -38.00K | 20.00K | 10.00K | |||
| Net Income | -13.19M | -20.51M | -22.73M | -16.93M | -10.75M | |||
| EBITDA | -11.66M | -19.11M | -20.96M | -16.61M | -12.24M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.40 | -0.65 | -0.74 | -0.55 | -0.36 | |||
| Statistics | ||||||||
All data in EUR